Pharma Pathway

SEPTEMBER 21, 2022

Hetero Labs Limited-Walk-In Interviews for EHS- Process Safety Management/ Process Safety Lab On 24th Sept’ 2022. The company is recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products. Departments: EHS- Process Safety Management/ Process Safety Lab.

Safety 83

Safety Management Pharmaceutical Manufacturing 83

Pharmaceutical Technology

MARCH 6, 2024

To protect patient safety and reduce recall risks, drug manufacturers must reduce particle contamination sources wherever possible.

Manufacturing 52

Manufacturing Safety Patients 52

European Pharmaceutical Review

AUGUST 17, 2023

The National Institutes of Health (NIH) has chosen contract development, and manufacturing organisation (CDMO) Exothera SA to develop the manufacturing process for its intranasal vaccine against SARS-CoV-2 coronavirus to treat COVID-19. MHRA authorises new COVID-19 vaccine What will the intranasal vaccine manufacturing project involve?

Manufacturing 93

Manufacturing Medicine Physicians Safety 93

Scott Burrows

MAY 2, 2023

It is Time to Get Accountable about Safety As a motivational safety team speaker , I am familiar with the many recent studies on isolation and loneliness. What this means for safety Workplace safety can only thrive in an environment of teamwork, where every member of the team, top to bottom, is accountable and engaged.

Safety 52

Safety Manufacturing Healthcare Healthcare 52

European Pharmaceutical Review

JANUARY 18, 2023

The first good manufacturing practice (GMP) registration of a UK pharmaceutical facility for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API) has been granted since the legalisation of medical cannabis in 2018. Thus, the MHRA’s approval supports improved regulation of medical cannabis manufacturing.

Manufacturing 113

Manufacturing Medical Medicine Pharmaceutical 113

European Pharmaceutical Review

NOVEMBER 20, 2023

billion parenteral (injectable) manufacturing site in Alzey, Rhineland-Palatinate, Germany. This includes automation and high-speed manufacturing lines. With the planned additional manufacturing facility in Alzey, the company will operate a total of six manufacturing sites in Europe.

Manufacturing 91

Manufacturing Medicine Biopharma Engineering 91

European Pharmaceutical Review

AUGUST 31, 2023

[pharmaceutical companies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.

Manufacturing 83

Manufacturing Medicine Management Pharmaceutical 83

PharmaTech

APRIL 17, 2024

Wenyu Zhang, PhD, addressed new trends in the aseptic industry and the chief concerns companies should keep in mind while weighing their options, at INTERPHEX 2024.

Safety 59

Safety Manufacturing 59

European Pharmaceutical Review

JUNE 15, 2023

This approach can also help determine the appropriate manufacturing processes, sterilisation methods, and maintenance procedures. However, the safety and efficacy of these devices can be compromised if they are not appropriately designed, manufactured, and maintained, the authors wrote. Sharma et al. Sharma et al.

Manufacturing 87

Manufacturing Medical Safety Transportation 87

MedCity News

APRIL 10, 2023

Greater collaboration among healthcare providers, medical device manufacturers, and lawmakers and regulators will lead to predictability and consistency in cybersecurity management. Together, we can make even greater strides toward patient safety and a more secure and sustainable healthcare system.

Manufacturing 90

Manufacturing Medical Healthcare Provider Safety 90

European Pharmaceutical Review

DECEMBER 4, 2023

To address these issues, companies should adopt more advanced production strategies such as continuous flow chemistry, as they can shorten manufacturing processes, increase productivity and throughput. Simultaneously, there is increasing need for stringent quality control and traceability throughout the supply chain to ensure patient safety.

Pharmaceutical manufacturing 97

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharmaceutical products 97

European Pharmaceutical Review

NOVEMBER 16, 2022

As the emphasis of new drug development gravitates towards new, ground-breaking therapies and vaccines, the requirements of manufacturing sites, equipment and processes need to be appropriate for this new environment. That is because of the relative expense of emerging therapies and the pressure on pricing for continuing product lines.

Manufacturing 116

Manufacturing Pharma Biopharma Management 116

European Pharmaceutical Review

JANUARY 27, 2023

The UK will be the first country to introduce a tailored framework for the regulation of innovative medicines manufactured at the point where a patient receives care, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced. Clear regulatory expectations and allowing easier product development.

Manufacturing 95

Manufacturing Medicine Consulting Engineering 95

PharmaTech

DECEMBER 5, 2022

For all stages throughout the development, manufacturing and release of your biological product, Eurofins BioPharma Product Testing offers comprehensive, fully cGMP-compliant Viral Safety Services, including characterization of cell banks, unprocessed bulk testing, end of production cells, and raw materials testing.

Safety 40

Safety Biopharma Manufacturing 40

European Pharmaceutical Review

JUNE 22, 2023

On 6 June 2023, the British Standards Institute (BSI) launched its Minimized Risk of Antimicrobial Resistance (AMR) certification for antibiotic manufacturing. According to the information sharing platform AMR Insights , AMR is considered one of the biggest global threats to health and food safety.

Manufacturing 87

Manufacturing Transportation Healthcare Healthcare 87

European Pharmaceutical Review

AUGUST 22, 2022

However, the biopharma industries realised that traditional vaccine development and manufacturing techniques, which take around five to 10 years for initial development to large-scale distribution, 1 were inadequate to meet the growing demand for COVID-19 vaccines. Digital technologies for smart vaccine manufacturing.

Manufacturing 94

Manufacturing Biopharma Engineering Safety 94

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Medicine 131

Medicine Manufacturing Specialization Pharmaceutical 131

Pharma Pathway

JANUARY 24, 2023

Hetero Labs Limited-Walk-In Interviews for Quality Control/ Quality Assurance/ Engineering/ Safety -EHS On 29th Jan’ 2023 Job Description Hetero Labs Limited is one of India’s generic pharmaceutical companies and the “world’s largest producer of anti- retroviral drugs”. Dear, Greetings from Hetero…!!

Engineering 74

Engineering Safety Pharmaceutical Manufacturing 74

Pharma Pathway

FEBRUARY 11, 2023

Cipla Limited – Walk-In Drive for Production-Formulations/ API/ Sterile Manufacturing/ Quality On 12th Feb’ 2023 Job Description Company Profile Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India.

Manufacturing 88

Manufacturing Safety Pharma Medicine 88

European Pharmaceutical Review

JUNE 29, 2022

How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. We now have GMP manufacturing sites and partners across more than 10 countries.

Ethics 91

Ethics Safety Manufacturing Medicine 91

Pharmaceutical Technology

MARCH 30, 2023

The US FDA has revealed its detailed budget proposal for FY2024, which would require pharma companies to name their active pharmaceutical ingredient (API) suppliers, restart President Biden’s Cancer Moonshot, inject cash into amyotrophic lateral sclerosis (ALS) research, and enforce stricter rules around manufacturing, recalls, and shortages.

Manufacturing 59

Manufacturing FDA Safety Pharma 59

Pharma Leaders

MAY 8, 2023

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

Manufacturing 52

Manufacturing Food and Drug Administration FDA Pharmaceutical manufacturing 52

PharmaTech

AUGUST 2, 2023

Current good manufacturing practices for oral solid dosage forms protect the product from contamination and potential errors.

Safety 52

Safety Manufacturing 52

eMediWrite

JULY 13, 2023

They play a crucial role in assuring the efficacy and safety of products given to patients. Laboratory Information Management Systems (LIMS), tailored to the needs of pharmaceutical manufacturing and quality assurance/quality control (QA/QC) laboratories, are proving to be a powerful force in enabling the industry to meet these challenges.

Pharmaceutical products 52

Pharmaceutical products Safety Pharmaceutical Pharmaceutical manufacturing 52

Pharma Pathway

FEBRUARY 19, 2023

Co – Operative Industrial Estate, Bachupally, Miyapur, Hyderabad SMS Pharmaceuticals Ltd- Walk-Ins for Freshers & Experienced in Production/ Quality Control/ Stores/ ETP/ Safety On 24th & 25th Feb’ 2023 24 & 24B, 36 & 37, S.V.

Safety 52

Safety Pharmaceutical Pharmaceutical manufacturing Manufacturing 52

European Pharmaceutical Review

AUGUST 25, 2022

The developability, safety and efficacy of a new product must also be considered when establishing commercially viable processes. The post Accelerating timelines for development and manufacture of multi-specific antibodies appeared first on European Pharmaceutical Review.

Manufacturing 97

Manufacturing Safety Pharmaceutical 97

Pharmaceutical Technology

OCTOBER 30, 2022

The system combines robustness and a high level of functional safety even under the most difficult off-highway operating conditions. Electronic assistance systems are the first stage of the automated construction site which can improve safety on the site and make driving easy. This article was originally published in Verdict.co.uk.

Safety 52

Safety Electronics Manufacturing Pharmaceutical 52

Pharma Pathway

SEPTEMBER 14, 2022

Walk-In Interviews for Manufacturing On 18th Sept’ 2022. Walk-In Interviews for Sterile (Manufacturing/ Compounding/ Aseptic Filling Production) / Engineering Operators/ Process Engineering Maintenance @ Dr. Reddy’s Laboratories Ltd. Department: Manufacturing. Reddy’s Laboratories Ltd.-Walk-In Job Description.

Manufacturing 77

Manufacturing Engineering Safety Pharmaceutical 77

PharmaTech

NOVEMBER 8, 2022

When looking to scale-up monoclonal antibody (mAb) manufacturing, a crucial challenge can be delivering sustained or improved product quality with productivity enhancements. Having consistent product quality is essential to ensure patient safety and product efficacy. Read the app note and discover the future of mAb manufacturing.

Manufacturing 40

Manufacturing Safety Patients 40

Pharma Pathway

SEPTEMBER 24, 2022

Biocon Biologics-Walk-In Drive for Manufacturing Department On 25th Sept’ 2022. Biocon Biologics, a fully integrated global biosimilars organization, invites you to a walk-In drive for Multiple Manufacturing positions based in Bangalore . Department: Manufacturing. Job Description. Diploma/ M.Tech. Job Location: Bengaluru.

Manufacturing 52

Manufacturing Safety Pharma 52

European Pharmaceutical Review

APRIL 11, 2024

Expirations of biologic patents has enabled manufacturers to enter the market and offer lower-cost alternatives of these drugs, according to the report. In-house manufacturing has become “increasingly popular” with biosimilar companies, according to the report. million by 2032, at 17.6 percent CAGR between 2023 and 2032.

Marketing 100

Marketing Competition Manufacturing Healthcare Provider 100

Curzon Consulting

NOVEMBER 15, 2021

If hip and knee implant manufacturers want to stay relevant, and “move the needle” on value creation, they need to play big or go home! Implant manufacturers need to provide additional services along the value chain, especially as health systems move towards value-based care models. 15th November 2021 1 Minutes.

Manufacturing 52

Manufacturing Consulting Healthcare Healthcare 52

Pharmaceutical Technology

APRIL 14, 2023

The US Food and Drug Administration (FDA) has rejected Eli Lilly’s biologic licence application (BLA) for the ulcerative colitis (UC) drug mirikizumab over manufacturing concerns. No concerns related to the clinical data package, safety or the medicine label. The regulator has issued a complete response letter.

Food and Drug Administration 52

Food and Drug Administration Manufacturing FDA Medicine 52

European Pharmaceutical Review

OCTOBER 25, 2023

The aim is to remove the regulatory burden of reassessment following certain changes and updates to a medical device by a manufacturer. The device may be reassessed to ensure the performance and safety of the device is negatively impacted. However, each regulator will have specific national guidance which manufacturers must follow.

Medical 98

Medical Food and Drug Administration Manufacturing Safety 98

Pharmaceutical Technology

JULY 29, 2022

Pfizer (New York, New York) and Moderna’s (Cambridge, Massachusetts) Omicron-specific Covid-19 vaccines are in late-stage development, have demonstrated good efficacy against the variant and will likely be available to the public later this year to provide an additional booster and increase demand for injectable manufacturing.

Manufacturing 52

Manufacturing Food and Drug Administration FDA Marketing 52

Pharmaceutical Commerce

FEBRUARY 15, 2024

There were no safety or efficacy issues identified in the FDA complete response letter for Lymphir, with no additional trials required.

FDA 52

FDA Safety Manufacturing Pharmaceutical 52

European Pharmaceutical Review

DECEMBER 19, 2023

Gene therapy manufacturing processes produce low yields, particularly in early product development stages. Often, if gene therapy manufacturers were to adhere to current release requirements, the outcome would be little, if any, remaining product for the clinic or patients who often have no other treatment options.

Manufacturing 86

Manufacturing Safety Pharma Pharmaceutical 86